Related references
Note: Only part of the references are listed.Impulsivity trait in the early symptomatic BACHD transgenic rat model of Huntington disease
Giuseppe Manfre et al.
BEHAVIOURAL BRAIN RESEARCH (2016)
Treatment with the MAO-A inhibitor clorgyline elevates monoamine neurotransmitter levels and improves affective phenotypes in a mouse model of Huntington disease
Marta Garcia-Miralles et al.
EXPERIMENTAL NEUROLOGY (2016)
Olesoxime suppresses calpain activation and mutant huntingtin fragmentation in the BACHD rat
Laura E. Clemens et al.
BRAIN (2015)
Dynamics and Mechanisms of CNS Myelination
Kathryn K. Bercury et al.
DEVELOPMENTAL CELL (2015)
Early white matter abnormalities, progressive brain pathology and motor deficits in a novel knock-in mouse model of Huntington's disease
Jing Jin et al.
HUMAN MOLECULAR GENETICS (2015)
Longitudinal change in white matter microstructure in Huntington's disease: The IMAGE-HD study
Govinda R. Poudel et al.
NEUROBIOLOGY OF DISEASE (2015)
Anti-semaphorin 4D immunotherapy ameliorates neuropathology and some cognitive impairment in the YAC128 mouse model of Huntington disease
Amber L. Southwell et al.
NEUROBIOLOGY OF DISEASE (2015)
Mutant Huntingtin Downregulates Myelin Regulatory Factor-Mediated Myelin Gene Expression and Affects Mature Oligodendrocytes
Brenda Huang et al.
NEURON (2015)
Disruption of astrocyte-neuron cholesterol cross talk affects neuronal function in Huntington's disease
M. Valenza et al.
CELL DEATH AND DIFFERENTIATION (2015)
Neuropsychiatry and White Matter Microstructure in Huntington's Disease
Sarah Gregory et al.
JOURNAL OF HUNTINGTONS DISEASE (2015)
Neurogenesis in the Striatum of the Adult Human Brain
Aurelie Ernst et al.
CELL (2014)
White matter integrity in premanifest and early Huntington's disease is related to caudate loss and disease progression
Marianne J. U. Novak et al.
CORTEX (2014)
The neuroanatomy of subthreshold depressive symptoms in Huntington's disease: a combined diffusion tensor imaging (DTI) and voxel-based morphometry (VBM) study
R. Sprengelmeyer et al.
PSYCHOLOGICAL MEDICINE (2014)
The structural correlates of functional deficits in early huntington's disease
Christine Delmaire et al.
HUMAN BRAIN MAPPING (2013)
Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data
Sarah J. Tabrizi et al.
LANCET NEUROLOGY (2013)
Choosing an animal model for the study of Huntington's disease
Mahmoud A. Pouladi et al.
NATURE REVIEWS NEUROSCIENCE (2013)
Structural MRI in Huntington's disease and recommendations for its potential use in clinical trials
Nellie Georgiou-Karistianis et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2013)
Oligodendroglia: metabolic supporters of axons
Brett M. Morrison et al.
TRENDS IN CELL BIOLOGY (2013)
Marked differences in neurochemistry and aggregates despite similar behavioural and neuropathological features of Huntington disease in the full-length BACHD and YAC128 mice
Mahmoud A. Pouladi et al.
HUMAN MOLECULAR GENETICS (2012)
A Novel BACHD Transgenic Rat Exhibits Characteristic Neuropathological Features of Huntington Disease
Libo Yu-Taeger et al.
JOURNAL OF NEUROSCIENCE (2012)
Oligodendroglia metabolically support axons and contribute to neurodegeneration
Youngjin Lee et al.
NATURE (2012)
Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity
Ursula Fuenfschilling et al.
NATURE (2012)
Identification and characterization of Huntington related pathology: An in vivo DKI imaging study
Ines Blockx et al.
NEUROIMAGE (2012)
Diffusion Tensor Imaging in Huntington's disease reveals distinct patterns of white matter degeneration associated with motor and cognitive deficits
India Bohanna et al.
BRAIN IMAGING AND BEHAVIOR (2011)
Peroxisome-Proliferator-Activated Receptor Gamma Coactivator 1 α Contributes to Dysmyelination in Experimental Models of Huntington's Disease
Zhongmin Xiang et al.
JOURNAL OF NEUROSCIENCE (2011)
Population-specific expression analysis (PSEA) reveals molecular changes in diseased brain
Alexandre Kuhn et al.
NATURE METHODS (2011)
Natural history of disease in the YAC128 mouse reveals a discrete signature of pathology in Huntington disease
Jeffrey B. Carroll et al.
NEUROBIOLOGY OF DISEASE (2011)
Emerging roles for cholesterol in Huntington's disease
Marta Valenza et al.
TRENDS IN NEUROSCIENCES (2011)
Oligodendrocytes: biology and pathology
Monika Bradl et al.
ACTA NEUROPATHOLOGICA (2010)
Striatal and white matter predictors of estimated diagnosis for Huntington disease
Jane S. Paulsen et al.
BRAIN RESEARCH BULLETIN (2010)
Transcriptional changes in Huntington disease identified using genome-wide expression profiling and cross-platform analysis
Kristina Becanovic et al.
HUMAN MOLECULAR GENETICS (2010)
Impairment of PGC-1alpha expression, neuropathology and hepatic steatosis in a transgenic mouse model of Huntington's disease following chronic energy deprivation
Rajnish K. Chaturvedi et al.
HUMAN MOLECULAR GENETICS (2010)
Cholesterol Defect Is Marked across Multiple Rodent Models of Huntington's Disease and Is Manifest in Astrocytes
Marta Valenza et al.
JOURNAL OF NEUROSCIENCE (2010)
Myelination and support of axonal integrity by glia
Klaus-Armin Nave
NATURE (2010)
Altered white matter microstructure in the corpus callosum in Huntington's disease: Implications for cortical disconnection
H. Diana Rosas et al.
NEUROIMAGE (2010)
Prevention of depressive behaviour in the YAC128 mouse model of Huntington disease by mutation at residue 586 of huntingtin
Mahmoud A. Pouladi et al.
BRAIN (2009)
Impaired PGC-1α function in muscle in Huntington's disease
Rajnish K. Chaturvedi et al.
HUMAN MOLECULAR GENETICS (2009)
Axon-glial signaling and the glial support of axon function
Klaus-Armin Nave et al.
ANNUAL REVIEW OF NEUROSCIENCE (2008)
Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice
Michelle Gray et al.
JOURNAL OF NEUROSCIENCE (2008)
Myelin breakdown and iron changes in Huntington's disease: Pathogenesis and treatment implications
George Bartzokis et al.
NEUROCHEMICAL RESEARCH (2007)
Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage
Alexandre Kuhn et al.
HUMAN MOLECULAR GENETICS (2007)
Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1α in Huntington's disease neurodegeneration
Patrick Weydt et al.
CELL METABOLISM (2006)
Transcriptional repression of PGC-α by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration
Libin Cui et al.
CELL (2006)
Diffusion tensor imaging in presymptomatic and early Huntington's disease: Selective white matter pathology and its relationship to clinical measures
H. Diana Rosas et al.
MOVEMENT DISORDERS (2006)
Cognitive dysfunction precedes neuropathology and motor abnormalities in the YAC128 mouse model of Huntington's disease
JM Van Raamsdonk et al.
JOURNAL OF NEUROSCIENCE (2005)
Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease
EJ Slow et al.
HUMAN MOLECULAR GENETICS (2003)
Share Paper
